Scientists tackle Huntington's disease by targeting mutant gene

Scientists tackle Huntington's disease by targeting mutant gene
Credit: Shutterstock

Huntington's disease is an inherited, neurodegenerative disorder that usually appears in mid-adult life and leads to uncoordinated body movements and cognitive decline. The disease is due to multiple repetitions of a deoxyribonucleic acid (DNA) sequence (i.e. the nucleotides CAG) in the gene encoding the 'Huntingtin' protein. This sequence is present more than 35 times in patients suffering from this disease, while it is repeated 10 to 29 times in healthy patients. In a recent study, published in the journal PNAS, researchers in Spain succeeded in reducing the chromosomal expression of the mutant gene, which could potentially hinder disease development.

Researchers say adult humans specifically need the Huntingtin protein, which is located in different tissues of the body, to ensure the development and survival of neurons. The presence of a results in an abnormal form of the Huntingtin protein. When this happens, the body is affected by a number of symptoms, including involuntary movements, behavioural changes and dementia. Despite inroads made into this condition, no one has been able to find a cure for Huntington's disease. Patients are currently treated to ease their pain and discomfort, and most patients die around 15 years after their symptoms first appear.

Scientists know that one gene is responsible for Huntington's disease, which is not the case for other neurological disorders like Parkinson or Alzheimer. So they are hopeful that developing a therapy based on the inhibition of the mutant Huntingtin gene could lead to the development of a treatment for it. Current studies focus on the modification of proteins that are contained in all living beings, such as the proteins (ZFP) that have the ability to recognise and bind to specific . Briefly, this process results in a regulated gene function.

Researchers from the CRG took their work one step further by reducing the chromosomal expression of the mutant gene, potentially hindering the development of the disease.

'We designed specific ZFP that recognize and specifically bind to more than 35 repetitions of CAG triplet, preventing the expression of the gene containing these repeats and reducing the production of the mutant ,' said lead author Mireia Garriga-Canut, a researcher from the Gene Network Engineering group at the CRG. 'When applying this treatment to a transgenic mouse model carrying the human mutant , we observed a delayed onset of the symptoms.'

Carmen Agustín Pavón, one of the authors of the study, said, 'The next step is to optimise the design for an effective and durable treatment for patients. This would pave the way to find a therapy for Huntington's disease.'

More information: Garriga-Canut, M., et al., 'Synthetic zinc finger repressors reduce mutant Huntingtin expression in the brain of R6/2 mice', PNAS, 2012. doi:10.1073/pnas.1206506109

add to favorites email to friend print save as pdf

Related Stories

A step toward controlling Huntington's disease?

Jun 23, 2011

Johns Hopkins researchers have identified a natural mechanism that might one day be used to block the expression of the mutated gene known to cause Huntington’s disease. Their experiments offer not an immediate cure, ...

Proposed drug may reverse Huntington's disease symptoms

Jun 20, 2012

With a single drug treatment, researchers at the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine can silence the mutated gene responsible for Huntington's ...

New insight into the cellular defects in Huntington's disease

Oct 10, 2011

Huntington disease is a devastating neurogenerative disorder that causes a progressive loss of functional capacity and reduced life span. It is an inherited condition caused by a mutant HTT gene. Although this has been known ...

Recommended for you

Scientists discover an on/off switch for aging cells

Sep 20, 2014

(Medical Xpress)—Scientists at the Salk Institute have discovered an on-and-off "switch" in cells that may hold the key to healthy aging. This switch points to a way to encourage healthy cells to keep dividing ...

Gene variant that dramatically reduces 'bad' lipids

Sep 16, 2014

In the first study to emerge from the UK10K Project's cohort of samples from the general public, scientists have identified a rare genetic variant that dramatically reduces levels of certain types of lipids in the blood. ...

New diagnostic method identifies genetic diseases

Sep 16, 2014

People with genetic diseases often have to embark on an odyssey from one doctor to the next. Fewer than half of all patients who are suspected of having a genetic disease actually receive a satisfactory diagnosis. Scientists ...

User comments